Anti-TMEM170B antibodies are used in the immunodetection of the protein transmembrane protein 170B. In humans, the canonical protein has a reported length of 132 amino acid residues and a mass of 14.4 kDa. Its subcellular localization is in the cell membrane. It is reported to be expressed in normal breast tissues. A member of the TMEM170 protein family, TMEM170B is reported to negatively regulate the canonical Wnt signaling in breast cancer cells. Post-translational modifications have been described, including glycosylation. TMEM170B gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. Some TMEM170B antibodies may have been used in research and have associated citations. Indicated applications for the antibodies listed below include Immunocytochemistry, Immunofluorescence, and Immunohistochemistry.